Iovance Biotherapeutics (IOVA) Earnings
|
Expand Research on IOVA
| Next EPS Date | 11/5/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -11.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +14.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.09 | N/A | N/A | $113.74M | N/A | N/A | N/A | ||
| 8/6/26 | Q226 | -$0.11 | -$0.13 | +$0.02 | $99.31M | $87.12M | N/A |  | | Details | |
| 5/7/26 | Q126 | -$0.19 | -$0.14 | -$0.05 | $71.43M | $80.93M | = | | | Details | |
| 2/24/26 | Q425 | -$0.18 | -$0.17 | -$0.01 | $86.71M | $82.03M | N/A | | | Details | |
| 11/6/25 |
Q325 | N/A | -$0.26 | N/A | N/A | $76.19M | = | N/A | N/A | ||
| 8/7/25 | Q225 | -$0.33 | -$0.28 | -$0.05 | $60M | $67.1M | = | | | Details | |
| 5/8/25 | Q125 | -$0.36 | -$0.24 | -$0.12 | $49.3M | $83.27M | = | | | Details | |
| 2/27/25 | Q424 | -$0.26 | -$0.27 | +$0.01 | $73.69M | $77.33M | = | | | Details |
